Total Funding
6
Total FundingSeries A raised
Growth Score in past quarter
pts
Heat Score 6 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
PrEP Biopharm is a developer of respiratory infectious disease products.
- Bruce A. Malcolm: Co-Founder and Chief Scientific Officer
About the Company
PrEP Biopharm is a biopharmaceutical company. That focused on the prevention of respiratory infections. They prevent upper respiratory tract viral infections. PrEP-001 is a phase 2 nasal spray that increases the host's innate immune response and protects against all respiratory viruses and is predicted to be used to combat respiratory viral
pandemics such as COVID-19.

